The bill gives the FDA authority to prevent drug shortages and speed reviews of medical devices, and also ensures the safety of drugs imported from abroad through the collection of fees from companies. Those fees will fund FDA inspections of foreign facilities and give drugmakers incentives to produce antibiotics to treat troublesome conditions.
The Senate recently passed its own FDA authorization bill, which is similar to the one the House passed but different on several fronts. The bills disagree on some medical device safety provisions and which antibiotics should qualify for incentives. Further, the Senate version includes room for a law that would implement a national system for tracking medications to cut down on fake or stolen drugs.
More Articles on the FDA:
Senate Passes FDA Safety and Innovation Act
Teleflex Receives FDA Clearance for Epidural Catheter
FDA Guidance Seeks to Reduce Radiation Exposure to Children
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
